KURE.L vs. XGES.L
KURE.L (KraneShares MSCI All China Health Care Index UCITS ETF USD) and XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds tracking the MSCI World/Health Care NR USD, from MLC Management and DWS respectively. Both are passively managed. Over the past year, KURE.L returned -10.89% vs 24.80% for XGES.L. At a 0.42 correlation, their price movements are largely independent. KURE.L charges 0.65%/yr vs 0.35%/yr for XGES.L.
Performance
KURE.L vs. XGES.L - Performance Comparison
Loading charts...
Different Trading Currencies
KURE.L is traded in USD, while XGES.L is traded in GBP. To make them comparable, the XGES.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, KURE.L achieves a -10.68% return, which is significantly lower than XGES.L's -1.06% return.
KURE.L
- 1D
- -2.87%
- 1M
- -12.38%
- YTD
- -10.68%
- 6M
- -19.51%
- 1Y
- -10.89%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XGES.L
- 1D
- 4.27%
- 1M
- 5.84%
- YTD
- -1.06%
- 6M
- -3.71%
- 1Y
- 24.80%
- 3Y*
- 4.13%
- 5Y*
- —
- 10Y*
- —
KURE.L vs. XGES.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
KURE.L KraneShares MSCI All China Health Care Index UCITS ETF USD | -10.68% | 11.52% |
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.06% | 29.08% |
Correlation
The correlation between KURE.L and XGES.L is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2025 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KURE.L vs. XGES.L — Risk / Return Rank
KURE.L
XGES.L
KURE.L vs. XGES.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index UCITS ETF USD (KURE.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KURE.L | XGES.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.64 | ||
| Sortino ratioReturn per unit of downside risk | -2.27 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.23 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.29 | 1.60 | -1.88 |
| Martin ratioReturn relative to average drawdown | -0.58 | 3.83 | -4.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KURE.L | XGES.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.33 | 1.32 | -1.64 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.01 | 0.04 | -0.05 |
Drawdowns
KURE.L vs. XGES.L - Drawdown Comparison
The maximum KURE.L drawdown since its inception was -30.31%, smaller than the maximum XGES.L drawdown of -32.16%. Use the drawdown chart below to compare losses from any high point for KURE.L and XGES.L.
Loading charts...
Drawdown Indicators
| KURE.L | XGES.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.31% | -32.16% | +1.85% |
Max Drawdown (1Y)Largest decline over 1 year | -30.31% | -15.47% | -14.84% |
Max Drawdown (3Y)Largest decline over 3 years | — | -25.76% | — |
Current DrawdownCurrent decline from peak | -30.31% | -7.39% | -22.92% |
Average DrawdownAverage peak-to-trough decline | -11.49% | -14.32% | +2.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.98% | 6.46% | +8.52% |
Volatility
KURE.L vs. XGES.L - Volatility Comparison
KraneShares MSCI All China Health Care Index UCITS ETF USD (KURE.L) has a higher volatility of 7.23% compared to Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) at 6.66%. This indicates that KURE.L's price experiences larger fluctuations and is considered to be riskier than XGES.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KURE.L | XGES.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.23% | 6.66% | +0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 18.31% | 14.54% | +3.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.92% | 18.82% | +8.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.64% | 19.93% | +6.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.64% | 19.93% | +6.71% |
KURE.L vs. XGES.L - Expense Ratio Comparison
KURE.L has a 0.65% expense ratio, which is higher than XGES.L's 0.35% expense ratio.
Dividends
KURE.L vs. XGES.L - Dividend Comparison
Neither KURE.L nor XGES.L has paid dividends to shareholders.
Frequently Asked Questions
KURE.L and XGES.L have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XGES.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XGES.L is cheaper with a 0.35% expense ratio, compared with 0.65% for KURE.L.
Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: MLC Management and DWS. Their fees differ too: 0.65% for KURE.L and 0.35% for XGES.L.
Find the right allocation for KURE.L and XGES.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer